4-((bis(2-chloroethyl)amino)((1-methyl-2-nitro-1H-imidazol-5-yl)methoxy)phosphorylamino)-N-ethyl-N,N-dimethylbutan-1-aminium iodide

ID: ALA4279260

Chembl Id: CHEMBL4279260

PubChem CID: 145981194

Max Phase: Preclinical

Molecular Formula: C17H34Cl2IN6O4P

Molecular Weight: 488.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[N+](C)(C)CCCCNP(=O)(OCc1cnc([N+](=O)[O-])n1C)N(CCCl)CCCl.[I-]

Standard InChI:  InChI=1S/C17H34Cl2N6O4P.HI/c1-5-25(3,4)13-7-6-10-21-30(28,23(11-8-18)12-9-19)29-15-16-14-20-17(22(16)2)24(26)27;/h14H,5-13,15H2,1-4H3,(H,21,28);1H/q+1;/p-1

Standard InChI Key:  ZBQBUITXQMREAJ-UHFFFAOYSA-M

Associated Targets(Human)

H-EMC-SS (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACAN Aggrecan core protein (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.38Molecular Weight (Monoisotopic): 487.1751AlogP: 3.20#Rotatable Bonds: 16
Polar Surface Area: 102.53Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.82CX Basic pKa: CX LogP: -2.63CX LogD: -2.63
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.10Np Likeness Score: -0.30

References

1. Ghedira D, Voissière A, Peyrode C, Kraiem J, Gerard Y, Maubert E, Vivier M, Miot-Noirault E, Chezal JM, Farhat F, Weber V..  (2018)  Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.,  158  [PMID:30199705] [10.1016/j.ejmech.2018.08.060]

Source